Burning Rock Biotech Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $371.0M | $290.5M |
| FY2021 | — | $289.6M | $224.6M |
| FY2022 | — | $167.9M | $131.3M |
| FY2023 | — | $108.2M | $86.6M |
| FY2024 | — | $79.6M | $71.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $371.0M | $290.5M |
| FY2021 | — | $289.6M | $224.6M |
| FY2022 | — | $167.9M | $131.3M |
| FY2023 | — | $108.2M | $86.6M |
| FY2024 | — | $79.6M | $71.2M |